Pathophysiology of the basal ganglia in Parkinson's disease

Trends Neurosci. 2000 Oct;23(10 Suppl):S8-19. doi: 10.1016/s1471-1931(00)00028-8.

Abstract

Insight into the organization of the basal ganglia in the normal, parkinsonian and L-dopa-induced dyskinesia states is critical for the development of newer and more effective therapies for Parkinson's disease. We believe that the basal ganglia can no longer be thought of as a unidirectional linear system that transfers information based solely on a firing-rate code. Rather, we propose that the basal ganglia is a highly organized network, with operational characteristics that simulate a non-linear dynamic system.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects*
  • Basal Ganglia / pathology
  • Basal Ganglia / physiopathology*
  • Disease Models, Animal
  • Dyskinesia, Drug-Induced / metabolism
  • Dyskinesia, Drug-Induced / physiopathology*
  • Dyskinesia, Drug-Induced / prevention & control
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / adverse effects*
  • Models, Neurological
  • Neural Pathways
  • Neurons / metabolism
  • Parkinson Disease / metabolism
  • Parkinson Disease / physiopathology*
  • Pulse Therapy, Drug / adverse effects*
  • Receptors, Dopamine / metabolism

Substances

  • Antiparkinson Agents
  • Receptors, Dopamine
  • Levodopa